BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 22/04/2026

FDA Classifies Sleep Apnea Testing Device for Mandibular Movement into Class II

The FDA has classified a device for sleep apnea testing based on mandibular movement into Class II, with special controls, to ensure safety and effectiveness, and to reduce regulatory burdens, ultimately enhancing patient access to innovative devices.

Source: Federal Register — Food and Drug AdministrationOpen original release →